This latter name is distinct from von Recklinghausen disease which is neurofibromatosis type 1
Castro, C.C.D., Silva, D.S.E., Costa, G.A., Fischer, G., Vargas, G.D.A., Brandelli, A., et al., Cincia Rural , 2017, vol
Nearly one in three GLP-1 users say theyre likely to make it look like they ate more than they actually did on Thanksgiving
Energy Expenditure Research The glucagon receptor component has generated interest regarding potential effects on calorie utilization and energy expenditure
The dose-response meta-analysis showed that higher doses of GLP-1 RAs were associated with increased risks of nausea, vomiting, diarrhea, constipation, and decreased appetite
Vaccine (2011) 29(12):226271